Evidence map›Paper›PMID 30034690›Full record

ArticleChemical science2016

A reactivity-based [

Wei Liu, Charles Truillet, Robert R Flavell, Thomas F Brewer, Michael J Evans, David M Wilson, Christopher J Chang

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Chemoenzymatic Syntheses of Fluorine-18-Labeled Disaccharides from [Journal of the American Chemical Society · 2023
    Article
  4. Review
  5. Distinct RNAProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Exploring Metabolism In Vivo Using EndogenousSeminars in nuclear medicine · 2017
    Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Wei LiuDepartment of Chemistry , University of Berkeley , Berkeley , CA 94720 , USA . Email: chrischang@berkeley.edu.
Charles TruilletDepartment of Radiology and Biomedical Imaging , University of California , San Francisco , California 94158 , USA . Email: David.M.Wilson@ucsf.edu.
Robert R FlavellDepartment of Radiology and Biomedical Imaging , University of California , San Francisco , California 94158 , USA . Email: David.M.Wilson@ucsf.edu.ORCID 0000-0002-8694-1199
Thomas F BrewerDepartment of Chemistry , University of Berkeley , Berkeley , CA 94720 , USA . Email: chrischang@berkeley.edu.
Michael J EvansDepartment of Radiology and Biomedical Imaging , University of California , San Francisco , California 94158 , USA . Email: David.M.Wilson@ucsf.edu.
David M WilsonDepartment of Radiology and Biomedical Imaging , University of California , San Francisco , California 94158 , USA . Email: David.M.Wilson@ucsf.edu.
Christopher J ChangDepartment of Chemistry , University of Berkeley , Berkeley , CA 94720 , USA . Email: chrischang@berkeley.edu.
University of California, San Francisco · USBerkeley College · USHoward Hughes Medical Institute · US

Funding

TR&D3: Open-Source Tools for Processing Hyperpolarized MR DataP41EB013598 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DUAN XU · 2011 to 2026
$19.9M
Molecular Imaging Probes To Study Redox BiologyR01GM079465 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Christopher J. Chang · 2006 to 2026
$7.8M
Univ of Calif Berkeley Chemistry-Biology Interface ProgramT32GM066698 · NIGMS · UNIVERSITY OF CALIFORNIA BERKELEY · PI CHANG, CHRISTOPHER J., FRANCIS, MATTHEW B · 2004 to 2023
$7.5M
Ascorbate-based biomarkers for predicting radiation response in prostate cancerR01CA166766 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WILSON, DAVID M · 2012 to 2016
$2.4M
Noninvasive measurement of oncogenic signaling pathways with 89Zr-transferrinR00CA172695 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EVANS, MICHAEL JOHN · 2014 to 2016
$728k
NCI NIH HHS R00 CA172695NCI NIH HHS R01 CA166766NIBIB NIH HHS P41 EB013598NIGMS NIH HHS R01 GM079465NIGMS NIH HHS T32 GM066698
6 · The paper itself

Abstract

Formaldehyde (FA) is a reactive carbonyl species (RCS) that plays a broad spectrum of roles in epigenetics, toxicology, and progression of diseases ranging from cancer to diabetes to neurodegeneration, motivating the development of translatable technologies for FA imaging. Here we report formaldehyde-caged-[

Identifiers

PMID30034690
PMCPMC6021783
OpenAlexW2397613441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.